14 July 2022 - Thousands of people a year with advanced breast cancer will benefit from a life extending drug that has been fast-tracked onto the frontline of NHS patient care.
The drug, alpelisib, will be used in combination with the hormone therapy, fulvestrant, to target the gene that causes fast growing tumours.